Department of Cardiac Surgery, Louis Pradel Cardiologic Hospital, Lyon, France.
Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Ann Thorac Surg. 2019 Mar;107(3):809-816. doi: 10.1016/j.athoracsur.2018.09.007. Epub 2018 Oct 23.
Cardiopulmonary resuscitation of cardiac arrest has poor outcomes. Extracorporeal life support (ECLS) could represent a salvage option. This study aimed to analyze the outcomes of ECLS used for refractory cardiac arrest.
In this observational analysis, patients were divided into an in-hospital cardiac arrest group (IHCA) and an out-of-hospital (OHCA) cardiac arrest group. The primary end point was survival to hospital discharge with good neurologic outcome. Both groups were compared after propensity score matching. Risk factors were searched with multivariate analyses.
From January 2007 to December 2016, study investigators performed 131 ECLS procedures (IHCA, n = 45, 34.4%; OHCA, n = 86, 65.6%). The mean age of patients was 43.2 years, and 71.8% were male. Baseline characteristics were comparable between both groups except mean no-flow duration (0.2 minutes vs 2.5 minutes; p < 0.001) and low-flow duration (46.9 minutes vs 85.3 minutes; p < 0.001), which were significantly shorter in the IHCA group. A total of 103 (82.4%) patients died during ECLS (IHCA, 79.1% vs OHCA, 84.1%; p = 0.479). The complication rate during ECLS was comparable between both groups. Twenty (16%) patients were successfully weaned from ECLS (IHCA, 18.6% vs OHCA, 14.6%; p = 0.565) after a mean support period of 6.7 days. Survival to hospital discharge with good neurologic outcome was not different between the two matched groups (odds ratio 1.3; 95% confidence interval, 0.023 to 74.902; p = 0.9). Presence of shockable rhythm was associated with a better outcome (odds ratio 6.674; 95% confidence interval, 1.078 to 41.336; p = 0.044).
Patients in the IHCA and OHCA groups experienced the same survival with good neurologic outcome after ECLS support. A better selection of patients with IHCA is mandatory to avoid futile support.
心脏骤停的心肺复苏效果不佳。体外生命支持(ECLS)可能是一种挽救措施。本研究旨在分析用于难治性心脏骤停的 ECLS 的结果。
在这项观察性分析中,患者分为院内心脏骤停组(IHCA)和院外心脏骤停(OHCA)组。主要终点是存活至出院且神经功能良好。对两组进行倾向评分匹配后进行比较。使用多变量分析搜索危险因素。
2007 年 1 月至 2016 年 12 月,研究人员共进行了 131 例 ECLS 治疗(IHCA,n=45,34.4%;OHCA,n=86,65.6%)。患者的平均年龄为 43.2 岁,71.8%为男性。两组的基线特征除无血流时间(0.2 分钟与 2.5 分钟;p<0.001)和低血流时间(46.9 分钟与 85.3 分钟;p<0.001)外,差异无统计学意义,IHCA 组的无血流时间和低血流时间明显较短。103 例(82.4%)患者在 ECLS 期间死亡(IHCA 为 79.1%,OHCA 为 84.1%;p=0.479)。两组的 ECLS 期间并发症发生率相当。20 例(16%)患者在 ECLS 支持后平均 6.7 天成功撤机(IHCA 为 18.6%,OHCA 为 14.6%;p=0.565)。两组匹配后出院时神经功能良好的存活率无差异(比值比 1.3;95%置信区间,0.023 至 74.902;p=0.9)。可除颤节律的存在与更好的结果相关(比值比 6.674;95%置信区间,1.078 至 41.336;p=0.044)。
在 ECLS 支持下,IHCA 和 OHCA 组的患者具有相同的生存和良好的神经功能结局。对 IHCA 患者进行更好的选择以避免无效支持是必要的。